#1 Clinical Trials Search in Europe

Dexamethasone Phosphate

This article examines the use of Dexamethasone Phosphate in various clinical trials. Dexamethasone Phosphate, a potent corticosteroid, is being studied for its potential benefits in treating conditions ranging from hearing loss to postoperative pain. The trials explore different administration methods and dosages to determine the drug’s efficacy and safety in various medical scenarios.

Table of Contents

What is Dexamethasone Phosphate?

Dexamethasone Phosphate is a type of medication known as a glucocorticoid, which is a class of steroid hormones. It is a synthetic version of naturally occurring hormones produced by the adrenal glands[1]. This medication is widely used in medical practice due to its powerful anti-inflammatory and immunosuppressive properties.

Dexamethasone Phosphate is known by several other names, including:

  • Decadron
  • Dexamethasone Intensol
  • Dexpak Taperpak
  • Zema Pak

These alternative names are important to know as you might encounter them on prescription labels or in discussions with healthcare providers[2].

Medical Uses

Dexamethasone Phosphate is used to treat a variety of medical conditions due to its ability to reduce inflammation and suppress the immune system. Some of the key uses include:

  1. Respiratory Conditions: It is used to reduce inflammation in the lungs of newborns, potentially preventing or treating a condition called respiratory distress syndrome. This is particularly important for babies born via cesarean section, who may be at higher risk for breathing difficulties[1].
  2. Eye Conditions: Dexamethasone Phosphate is used in the treatment of various eye conditions, including macular edema (swelling in the back of the eye) and inflammation after cataract surgery[3][4].
  3. Hearing Disorders: It may be used to treat sudden hearing loss and to prevent hearing loss caused by certain chemotherapy drugs[2][5].
  4. Pain Management: Dexamethasone Phosphate is being studied for its potential to reduce pain after various surgical procedures[6].
  5. Cancer Treatment: While not a cancer treatment itself, it’s often used alongside chemotherapy to help manage side effects like nausea and inflammation[2].

Administration Methods

Dexamethasone Phosphate can be administered in several ways, depending on the condition being treated:

  • Intramuscular Injection: The medication is injected into a muscle, often used before cesarean sections to help mature the baby’s lungs[1].
  • Intravenous Injection: Administered directly into a vein, often used in hospital settings for rapid effect[6].
  • Eye Drops or Eye Injections: Used for various eye conditions[3][4].
  • Intratympanic Injection: Injected into the middle ear for certain hearing disorders[2][5].
  • Nerve Block: Used in combination with other medications for pain management in certain surgical procedures[7].

Potential Side Effects

While Dexamethasone Phosphate can be very effective, it may also cause side effects. Some potential side effects include:

  • Increased blood sugar levels
  • Changes in mood or behavior
  • Increased risk of infections
  • Changes in appetite
  • Fluid retention
  • Slow wound healing

In specific uses, such as in eye treatments, it may cause increased eye pressure or other eye-related side effects[3][4]. When used for pain management, potential side effects may include changes in heart rate or blood pressure[7].

Ongoing Research

Researchers continue to study Dexamethasone Phosphate to understand its full potential and optimize its use. Current areas of research include:

  • Its effectiveness in reducing inflammation and pain after various types of surgery[6].
  • Its potential to prevent hearing loss caused by certain chemotherapy drugs[2].
  • New methods of delivering the medication, such as through the skin for eye conditions[3][4].
  • Its use in combination with other medications for pain management[7].

These ongoing studies aim to improve treatment outcomes and reduce side effects for patients using Dexamethasone Phosphate.

Aspect Details
Conditions Studied Hearing loss, sciatica, macular edema, neonatal respiratory distress, postoperative pain
Administration Methods Intratympanic, sacrococcygeal, postauricular, intramuscular, ocular iontophoresis, intravenous, nerve block
Potential Benefits Hearing protection, pain reduction, fetal lung maturation, vision improvement, surgical stress reduction
Outcome Measures Audiometry, pain scales, imaging studies, blood tests, quality of life questionnaires
Safety Monitoring Adverse reactions, vital signs, postoperative complications
Trial Designs Randomized controlled, double-blind, placebo-controlled, open-label
Patient Populations Adults, pregnant women, neonates, surgical patients

FAQ

  • What conditions is Dexamethasone Phosphate being tested for in these clinical trials? Dexamethasone Phosphate is being tested for a variety of conditions including cisplatin-induced hearing loss, refractory sciatica, sudden hearing loss, neonatal respiratory distress syndrome, macular edema, and postoperative pain management after robotic-assisted hysterectomy and thyroidectomy.
  • How is Dexamethasone Phosphate administered in these trials? The administration methods vary depending on the trial and condition being treated. They include intratympanic injection, echo-guided infiltration through the sacrococcygeal hiatus, postauricular injection, intramuscular injection, ocular iontophoresis, intravenous infusion, and as part of a nerve block.
  • What are some potential benefits of using Dexamethasone Phosphate? Potential benefits include protection against hearing loss, reduction of inflammation and pain, enhancement of fetal lung maturity, improvement in macular edema, reduction of surgical stress response, and improved postoperative recovery.
  • Are there any side effects associated with Dexamethasone Phosphate use in these trials? While specific side effects are not detailed in all trials, some studies monitor for adverse reactions such as bradycardia, hypotension, dysrhythmia, and postoperative nausea and vomiting. The safety profile is being evaluated as part of these clinical trials.
  • How do researchers measure the effectiveness of Dexamethasone Phosphate in these trials? Effectiveness is measured through various means depending on the condition being treated. These include audiometric tests, pain scales, imaging studies (like OCT for macular edema), blood tests for inflammatory markers, and questionnaires assessing quality of recovery and functional outcomes.

Ongoing Clinical Trials on Dexamethasone Phosphate

  • Study of venetoclax, obinutuzumab and zanubrutinib combination therapy in young patients with high-risk Chronic Lymphocytic Leukemia and residual disease

    Recruiting

    2 1 1 1
    Investigated drugs:
    Italy

  • Study on Long-Term Safety of mRNA-3705 for Patients with Methylmalonic Acidemia (MMA)

    Recruiting

    2 1 1 1
    Investigated drugs:
    France The Netherlands Spain

  • Study on Palonosetron and Netupitant for Preventing Nausea in Endometrial Cancer Patients Undergoing Taxane-Platinum Chemotherapy

    Recruiting

    3 1 1 1
    Investigated drugs:
    Italy

  • Study of Tebentafusp and Pembrolizumab for Patients with Previously Treated Advanced Melanoma

    Recruiting

    4 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium France Germany Italy Poland +1

  • Study on Dexamethasone Phosphate for Reducing Breathing Problems in Children with Upper Airway Obstruction in Intensive Care

    Recruiting

    3 1 1
    Investigated drugs:
    France

  • Study of nivolumab plus drug combination versus standard first-line therapy in patients with advanced Hodgkin lymphoma

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Poland

  • A Study of Linvoseltamab Alone and Linvoseltamab with Carfilzomib Compared to Standard Treatment in Adults with Relapsed or Refractory Multiple Myeloma

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Czechia France Germany Greece +4

  • Study of How Enzalutamide and Apalutamide Affect Dexamethasone Processing in the Body in Patients with Prostate Cancer

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Sweden

  • Study of Ropivacaine and Dexamethasone Nerve Block for Patients with Acute Low Back Pain

    Not yet recruiting

    3 1 1
    Investigated drugs:
    France

  • Study on the effectiveness of dexamethasone and chloroprocaine in extending the effects of spinal anesthesia for patients undergoing knee arthroscopy

    Not yet recruiting

    3 1 1
    Investigated drugs:
    France

Glossary

  • Dexamethasone Phosphate: A synthetic corticosteroid medication used for its anti-inflammatory and immunosuppressive properties. It is being studied in various forms and applications for treating different medical conditions.
  • Intratympanic injection: A method of delivering medication directly into the middle ear by injecting it through the eardrum. This technique is used in some trials studying treatments for hearing loss.
  • Cisplatin: A chemotherapy drug used to treat various types of cancers. It can cause hearing loss as a side effect, which some trials aim to prevent using Dexamethasone Phosphate.
  • Ototoxicity: Damage to the ear (particularly to the cochlea or auditory nerve) caused by exposure to certain medications or chemicals, resulting in hearing loss.
  • Macular edema: A condition where fluid accumulates in the macula, the central part of the retina, causing swelling and potentially affecting vision.
  • Ocular iontophoresis: A non-invasive method of delivering medication to the eye using a low electrical current to drive charged molecules across the eye's surface.
  • Cervical plexus block: A regional anesthesia technique that numbs the nerves supplying the neck and shoulder region, used in some surgeries like thyroidectomy.
  • C-reactive protein (CRP): A protein produced by the liver in response to inflammation. It is used as a marker to measure the body's inflammatory response in some clinical trials.
  • Neonatal respiratory distress syndrome (RDS): A breathing disorder that affects newborns, usually premature babies, where the lungs are not fully developed and lack a substance (surfactant) that helps keep air sacs open.
  • Transcriptional profiling: A technique used to study the RNA molecules produced by genes, which can provide insights into how genes are activated in response to treatments or conditions.

References

  1. https://clinicaltrials.gov/study/NCT04816097
  2. https://clinicaltrials.gov/study/NCT01372904
  3. https://clinicaltrials.gov/study/NCT02485249
  4. https://clinicaltrials.gov/study/NCT02571556
  5. https://clinicaltrials.gov/study/NCT02026479
  6. https://clinicaltrials.gov/study/NCT04762381
  7. https://clinicaltrials.gov/study/NCT05793060